Marinus Pharmaceuticals (MRNS) director Johnson received 2,300 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Marvin Johnson (director at Marinus Pharmaceuticals Inc., MRNS) reported that they received 2,300 shares on Jun 18, 2024. After these transactions the filing shows 14,100 shares held directly.
- Reporting person
- Johnson Marvin
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 18, 2024 | Grant or award (A) | Common Stock1 | +2,300 | - | - | 14,100 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 18, 2024 | Grant or award (A) | Stock Option (Right to Buy)On 10,450 Common Stock2 | +10,450 | - | - | 10,450 direct |
Holdings before and after
- Common Stock: 11,800 to 14,100 direct
- Stock Option (Right to Buy): 0 to 10,450 direct
Footnotes from the filing
- 1. Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- 2. The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Johnson report in this MRNS Form 4?
Marvin Johnson (director at Marinus Pharmaceuticals Inc., MRNS) reported that they received 2,300 shares on Jun 18, 2024. After these transactions the filing shows 14,100 shares held directly.
How many MRNS shares does Johnson hold after this filing?
The filing shows 14,100 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for MRNS
Earlier insider filings at MRNS
- Jun 20, 2024Director Fischer Seth H. Z. was granted 2,300 shares, increasing direct ownership by 22% to 12,926 units (SEC Form 4)
- Jun 20, 2024Director Ezickson Elan was granted 2,300 shares, increasing direct ownership by 23% to 12,500 units (SEC Form 4)
- Jun 20, 2024Director Austin Charles was granted 2,300 shares, increasing direct ownership by 23% to 12,177 units (SEC Form 4)
- Jun 20, 2024CHIEF COMMERCIAL OFFICER Shafer Christina was granted 10,918 shares, increasing direct ownership by 18% to 71,226 units (SEC Form 4)
- Jun 20, 2024SVP, GEN. COUNSEL & CORP. SEC. Manning Martha E was granted 10,918 shares, increasing direct ownership by 21% to 63,884 units (SEC Form 4)
Quantisnow market dataNASDAQ
MRNS
Marinus Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for MRNS
Full MRNS profile on Quantisnow Follow MRNS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time